Global Alpha- Antitrypsin Deficiency Treatment Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Alpha- Antitrypsin Deficiency Treatment

• 1.1 Definition of Alpha- Antitrypsin Deficiency Treatment
• 1.2 Alpha- Antitrypsin Deficiency Treatment Segment by Type
  • 1.2.1 Global Alpha- Antitrypsin Deficiency Treatment Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 CT-2009
  • 1.2.3 POL-6014
  • 1.2.4 ARO-AAT
  • 1.2.5 ALNAAT-02
  • 1.2.6 Others
• 1.3 Alpha- Antitrypsin Deficiency Treatment Segment by Applications
  • 1.3.1 Global Alpha- Antitrypsin Deficiency Treatment Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Global Alpha- Antitrypsin Deficiency Treatment Overall Market
  • 1.4.1 Global Alpha- Antitrypsin Deficiency Treatment Revenue (2014-2025)
  • 1.4.2 Global Alpha- Antitrypsin Deficiency Treatment Production (2014-2025)
  • 1.4.3 North America Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)
  • 1.4.4 Europe Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)
  • 1.4.5 China Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)
  • 1.4.6 Japan Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)
  • 1.4.8 India Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Alpha- Antitrypsin Deficiency Treatment
• 2.3 Manufacturing Process Analysis of Alpha- Antitrypsin Deficiency Treatment
• 2.4 Industry Chain Structure of Alpha- Antitrypsin Deficiency Treatment

3 Development and Manufacturing Plants Analysis of Alpha- Antitrypsin Deficiency Treatment

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Alpha- Antitrypsin Deficiency Treatment Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Alpha- Antitrypsin Deficiency Treatment
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Alpha- Antitrypsin Deficiency Treatment Production and Capacity Analysis
• 4.2 Alpha- Antitrypsin Deficiency Treatment Revenue Analysis
• 4.3 Alpha- Antitrypsin Deficiency Treatment Price Analysis
• 4.4 Market Concentration Degree

5 Alpha- Antitrypsin Deficiency Treatment Regional Market Analysis

• 5.1 Alpha- Antitrypsin Deficiency Treatment Production by Regions
  • 5.1.1 Global Alpha- Antitrypsin Deficiency Treatment Production by Regions
  • 5.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue by Regions
• 5.2 Alpha- Antitrypsin Deficiency Treatment Consumption by Regions
• 5.3 North America Alpha- Antitrypsin Deficiency Treatment Market Analysis
  • 5.3.1 North America Alpha- Antitrypsin Deficiency Treatment Production
  • 5.3.2 North America Alpha- Antitrypsin Deficiency Treatment Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Alpha- Antitrypsin Deficiency Treatment Import and Export
• 5.4 Europe Alpha- Antitrypsin Deficiency Treatment Market Analysis
  • 5.4.1 Europe Alpha- Antitrypsin Deficiency Treatment Production
  • 5.4.2 Europe Alpha- Antitrypsin Deficiency Treatment Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Alpha- Antitrypsin Deficiency Treatment Import and Export
• 5.5 China Alpha- Antitrypsin Deficiency Treatment Market Analysis
  • 5.5.1 China Alpha- Antitrypsin Deficiency Treatment Production
  • 5.5.2 China Alpha- Antitrypsin Deficiency Treatment Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Alpha- Antitrypsin Deficiency Treatment Import and Export
• 5.6 Japan Alpha- Antitrypsin Deficiency Treatment Market Analysis
  • 5.6.1 Japan Alpha- Antitrypsin Deficiency Treatment Production
  • 5.6.2 Japan Alpha- Antitrypsin Deficiency Treatment Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Alpha- Antitrypsin Deficiency Treatment Import and Export
• 5.7 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Analysis
  • 5.7.1 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Production
  • 5.7.2 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Import and Export
• 5.8 India Alpha- Antitrypsin Deficiency Treatment Market Analysis
  • 5.8.1 India Alpha- Antitrypsin Deficiency Treatment Production
  • 5.8.2 India Alpha- Antitrypsin Deficiency Treatment Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Alpha- Antitrypsin Deficiency Treatment Import and Export

6 Alpha- Antitrypsin Deficiency Treatment Segment Market Analysis (by Type)

• 6.1 Global Alpha- Antitrypsin Deficiency Treatment Production by Type
• 6.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue by Type
• 6.3 Alpha- Antitrypsin Deficiency Treatment Price by Type

7 Alpha- Antitrypsin Deficiency Treatment Segment Market Analysis (by Application)

• 7.1 Global Alpha- Antitrypsin Deficiency Treatment Consumption by Application
• 7.2 Global Alpha- Antitrypsin Deficiency Treatment Consumption Market Share by Application (2014-2019)

8 Alpha- Antitrypsin Deficiency Treatment Major Manufacturers Analysis

• 8.1 Adverum Biotechnologies, Inc.
  • 8.1.1 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 8.1.2 Adverum Biotechnologies, Inc. Product Introduction, Application and Specification
  • 8.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Alnylam Pharmaceuticals, Inc.
  • 8.2.1 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 8.2.2 Alnylam Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Applied Genetic Technologies Corporation
  • 8.3.1 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 8.3.2 Applied Genetic Technologies Corporation Product Introduction, Application and Specification
  • 8.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Arrowhead Pharmaceuticals, Inc.
  • 8.4.1 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 8.4.2 Arrowhead Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Carolus Therapeutics, Inc.
  • 8.5.1 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 8.5.2 Carolus Therapeutics, Inc. Product Introduction, Application and Specification
  • 8.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Cevec Pharmaceuticals GmbH
  • 8.6.1 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 8.6.2 Cevec Pharmaceuticals GmbH Product Introduction, Application and Specification
  • 8.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Dicerna Pharmaceuticals, Inc.
  • 8.7.1 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 8.7.2 Dicerna Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Digna Biotech, S.L.
  • 8.8.1 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 8.8.2 Digna Biotech, S.L. Product Introduction, Application and Specification
  • 8.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Editas Medicine, Inc.
  • 8.9.1 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 8.9.2 Editas Medicine, Inc. Product Introduction, Application and Specification
  • 8.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Grifols, S.A.
  • 8.10.1 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
  • 8.10.2 Grifols, S.A. Product Introduction, Application and Specification
  • 8.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Inhibrx
• 8.12 Intellia Therapeutics, Inc.
• 8.13 International Stem Cell Corporation
• 8.14 Ionis Pharmaceuticals, Inc.
• 8.15 Kamada Ltd.
• 8.16 Polyphor Ltd.
• 8.17 ProMetic Life Sciences Inc.
• 8.18 rEVO Biologics, Inc.
• 8.19 Sangamo BioSciences, Inc.

9 Development Trend of Analysis of Alpha- Antitrypsin Deficiency Treatment Market

• 9.1 Global Alpha- Antitrypsin Deficiency Treatment Market Trend Analysis
  • 9.1.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Alpha- Antitrypsin Deficiency Treatment Regional Market Trend
  • 9.2.1 North America Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
  • 9.2.2 Europe Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
  • 9.2.3 China Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
  • 9.2.4 Japan Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
  • 9.2.5 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
  • 9.2.6 India Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
• 9.3 Alpha- Antitrypsin Deficiency Treatment Market Trend (Product Type)
• 9.4 Alpha- Antitrypsin Deficiency Treatment Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Alpha- Antitrypsin Deficiency Treatment Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List